NeoGenomics, Inc. (NASDAQ:NEO) – Research analysts at SVB Leerink cut their Q2 2020 EPS estimates for NeoGenomics in a note issued to investors on Monday, March 30th. SVB Leerink analyst P. Souda no
Bitcoin had another down day. How long the cryptocurrency follows stocks, and whether next month’s halving juices its price, remain open questions.
FT. MYERS, FL / ACCESSWIRE / April 1, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its first quarter 2
Bank of New York Mellon Corp raised its holdings in NeoGenomics, Inc. (NASDAQ:NEO) by 2.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,530
Archer Investment Corp purchased a new stake in shares of NeoGenomics, Inc. (NASDAQ:NEO) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund purchased 1,1

Do Hedge Funds Love Brady Corp (BRC)?

01:26am, Monday, 30'th Mar 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa
Wall Street analysts expect NeoGenomics, Inc. (NASDAQ:NEO) to post $0.02 earnings per share for the current fiscal quarter, according to Zacks. Four analysts have made estimates for NeoGenomics’ ear
After looking at NeoGenomics, Inc.'s (NasdaqCM:NEO) latest earnings announcement (31 December 2019), I found it useful...
Wall Street analysts expect NeoGenomics, Inc. (NASDAQ:NEO) to post $105.89 million in sales for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for NeoGenomics’ earnin

Reviving A Comatose Economy

03:34pm, Thursday, 26'th Mar 2020
A deliberate slowing down of the economy is in progress in order to preserve it. The key question remains how soon can we start recovering. The expected $2 tril
Amalgamated Bank grew its holdings in shares of NeoGenomics, Inc. (NASDAQ:NEO) by 16.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). Th
The Neo Foundation released more than $11 million in NEO from locked accounts to cover costs for 2020.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE